Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 9, 2013 - Issue 9
Submit an article Journal homepage
1,337
Views
22
CrossRef citations to date
0
Altmetric
Commentary

Interleukin-15 dendritic cells as vaccine candidates for cancer immunotherapy

Sébastien Anguille Vaccine & Infectious Disease Institute; Laboratory of Experimental Hematology; Tumor Immunology Group (TIGR); University of Antwerp; Antwerp, Belgium; Center for Cell Therapy & Regenerative Medicine; Antwerp University Hospital; Antwerp, BelgiumCorrespondence[email protected]
,
Eva Lion Vaccine & Infectious Disease Institute; Laboratory of Experimental Hematology; Tumor Immunology Group (TIGR); University of Antwerp; Antwerp, Belgium
,
Johan Van den Bergh Vaccine & Infectious Disease Institute; Laboratory of Experimental Hematology; Tumor Immunology Group (TIGR); University of Antwerp; Antwerp, Belgium
,
Heleen H Van Acker Vaccine & Infectious Disease Institute; Laboratory of Experimental Hematology; Tumor Immunology Group (TIGR); University of Antwerp; Antwerp, Belgium
,
Yannick Willemen Vaccine & Infectious Disease Institute; Laboratory of Experimental Hematology; Tumor Immunology Group (TIGR); University of Antwerp; Antwerp, Belgium; Center for Cell Therapy & Regenerative Medicine; Antwerp University Hospital; Antwerp, Belgium
,
Evelien L Smits Vaccine & Infectious Disease Institute; Laboratory of Experimental Hematology; Tumor Immunology Group (TIGR); University of Antwerp; Antwerp, Belgium; Center for Cell Therapy & Regenerative Medicine; Antwerp University Hospital; Antwerp, Belgium
,
Viggo F Van Tendeloo Vaccine & Infectious Disease Institute; Laboratory of Experimental Hematology; Tumor Immunology Group (TIGR); University of Antwerp; Antwerp, Belgium
&
Zwi N Berneman Vaccine & Infectious Disease Institute; Laboratory of Experimental Hematology; Tumor Immunology Group (TIGR); University of Antwerp; Antwerp, Belgium; Center for Cell Therapy & Regenerative Medicine; Antwerp University Hospital; Antwerp, Belgium
 show all
Pages 1956-1961 | Received 31 May 2013, Accepted 11 Jun 2013, Published online: 18 Jun 2013

Citations (22)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Heleen H Van Acker, Sébastien Anguille, Viggo F Van Tendeloo & Eva Lion. (2015) Empowering gamma delta T cells with antitumor immunity by dendritic cell-based immunotherapy. OncoImmunology 4:8.
Read now
Daphné Benteyn, Carlo Heirman, Aude Bonehill, Kris Thielemans & Karine Breckpot. (2015) mRNA-based dendritic cell vaccines. Expert Review of Vaccines 14:2, pages 161-176.
Read now

Articles from other publishers (20)

Armin Mahmoud Salehi Kheshti, Farnaz Hajizadeh, Asal Barshidi, Bentolhoda Rashidi, Farbod Ebrahimi, Simin Bahmanpour, Vahid Karpisheh, Fatemeh Karimian Noukabadi, Fariba Karoon Kiani, Hadi Hassannia, Fatemeh Atyabi, Seyed Hossein Kiaie, Fatah Kashanchi, Jamshid Gholizadeh Navashenaq, Hamed Mohammadi, Rafieh Bagherifar, Reza Jafari, Naime Majidi Zolbanin & Farhad Jadidi-Niaragh. (2022) RETRACTED ARTICLE: Combination Cancer Immunotherapy with Dendritic Cell Vaccine and Nanoparticles Loaded with Interleukin-15 and Anti-beta-catenin siRNA Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response. Pharmaceutical Research 39:2, pages 353-367.
Crossref
Junichi MurakamiLicun Wu, Mikihiro KohnoMei-Lin Chan, Yidan Zhao, Zhihong Yun, B. C. John Cho & Marc de Perrot. (2021) Triple-modality therapy maximizes antitumor immune responses in a mouse model of mesothelioma. Science Translational Medicine 13:589.
Crossref
Roza Nurieva, Margarita Divenko & Sang Kim. 2021. Rheumatic Diseases and Syndromes Induced by Cancer Immunotherapy. Rheumatic Diseases and Syndromes Induced by Cancer Immunotherapy 3 29 .
Robert E. Hollingsworth & Kathrin Jansen. (2019) Turning the corner on therapeutic cancer vaccines. npj Vaccines 4:1.
Crossref
Ananda Mookerjee, Michele Graciotti & Lana E. Kandalaft. (2019) IL-15 and a Two-Step Maturation Process Improve Bone Marrow-Derived Dendritic Cell Cancer Vaccine. Cancers 11:1, pages 40.
Crossref
Heleen H. Van Acker, Sébastien Anguille, Hans De Reu, Zwi N. Berneman, Evelien L. Smits & Viggo F. Van Tendeloo. (2018) Interleukin-15-Cultured Dendritic Cells Enhance Anti-Tumor Gamma Delta T Cell Functions through IL-15 Secretion. Frontiers in Immunology 9.
Crossref
Tiange Chen, Yajing Zhang, Zhao Wang, Jie Yang, Mingming Li, Kunlun Wang, Min Cui, Zhen F. Fu, Ling Zhao & Ming Zhou. (2017) Recombinant rabies virus expressing IL-15 enhances immunogenicity through promoting the activation of dendritic cells in mice. Virologica Sinica 32:4, pages 317-327.
Crossref
. (2017) . The Japanese Journal of SURGICAL METABOLISM and NUTRITION 51:1, pages 25-32.
Crossref
Manoj Patidar, Naveen Yadav & Sarat K. Dalai. (2016) Interleukin 15: A key cytokine for immunotherapy. Cytokine & Growth Factor Reviews 31, pages 49-59.
Crossref
George Malietzis, Gui Han Lee, Hafid O. Al-Hassi, David Bernardo, Alexandra I. F. Blakemore, Robin H. Kennedy, Morgan Moorghen, John T. Jenkins & Stella C. Knight. (2016) Body composition of the host influences dendritic cell phenotype in patients treated for colorectal cancer. Tumor Biology 37:8, pages 11359-11364.
Crossref
Silvia Martin Lluesma, Anita Wolfer, Alexandre Harari & Lana Kandalaft. (2016) Cancer Vaccines in Ovarian Cancer: How Can We Improve?. Biomedicines 4:2, pages 10.
Crossref
Lien Vandenberk, Jochen Belmans, Matthias Van Woensel, Matteo Riva & Stefaan W. Van Gool. (2016) Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines. Frontiers in Immunology 6.
Crossref
Evelien L. J. M. Smits, Barbara Stein, Griet Nijs, Eva Lion, Viggo F. Van Tendeloo, Yannick Willemen, Sébastien Anguille & Zwi N. Berneman. 2016. Tumor Immunology. Tumor Immunology 27 35 .
Johan Van den Bergh, Yannick Willemen, Eva Lion, Heleen Van Acker, Hans De Reu, Sébastien Anguille, Herman Goossens, Zwi Berneman, Viggo Van Tendeloo & Evelien Smits. (2015) Transpresentation of interleukin-15 by IL-15/IL-15Rα mRNA-engineered human dendritic cells boosts antitumoral natural killer cell activity. Oncotarget 6:42, pages 44123-44133.
Crossref
Bana Jabri & Valérie Abadie. (2015) IL-15 functions as a danger signal to regulate tissue-resident T cells and tissue destruction. Nature Reviews Immunology 15:12, pages 771-783.
Crossref
Sébastien Anguille, Evelien L. Smits, Christian Bryant, Heleen H. Van Acker, Herman Goossens, Eva Lion, Phillip D. Fromm, Derek N. Hart, Viggo F. Van Tendeloo & Zwi N. Berneman. (2015) Dendritic Cells as Pharmacological Tools for Cancer Immunotherapy. Pharmacological Reviews 67:4, pages 731-753.
Crossref
Jashodeep Datta, Erik Berk, Jessica A. Cintolo, Shuwen Xu, Robert E. Roses & Brian J. Czerniecki. (2015) Rationale for a Multimodality Strategy to Enhance the Efficacy of Dendritic Cell-Based Cancer Immunotherapy. Frontiers in Immunology 6.
Crossref
Sébastien Anguille, Heleen H. Van Acker, Johan Van den Bergh, Yannick Willemen, Herman Goossens, Viggo F. Van Tendeloo, Evelien L. Smits, Zwi N. Berneman & Eva Lion. (2015) Interleukin-15 Dendritic Cells Harness NK Cell Cytotoxic Effector Function in a Contact- and IL-15-Dependent Manner. PLOS ONE 10:5, pages e0123340.
Crossref
Starlyn Okada, Shuhong Han, Ekta S Patel, Li‐Jun Yang & Lung‐Ji Chang. (2015) STAT3 signaling contributes to the high effector activities of interleukin‐15‐derived dendritic cells. Immunology & Cell Biology 93:5, pages 461-471.
Crossref
Sébastien Anguille, Evelien L Smits, Eva Lion, Viggo F van Tendeloo & Zwi N Berneman. (2014) Clinical use of dendritic cells for cancer therapy. The Lancet Oncology 15:7, pages e257-e267.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.